14.5 C
London
Monday, October 13, 2025
- Advertisement -

TAG

Biogen

Biogen to bolster rare disease treatments with £5.4 billion Reata acquisition

Biogen is spending more than seven billion US dollars (£5.4 billion) to buy Reata Pharmaceuticals and bolster its rare disease treatments. The Alzheimer’s treatment developer...

Latest news

- Advertisement -